Clinical Trial Update: A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a new IL-2–based treatment for primary smear-positive pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Drugs mentioned

• A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 (Interleukin-2)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Tuberculosis, Pulmonary | Phase 4 | Status: UNKNOWN